U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C13H10O3
Molecular Weight 214.2167
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PHENYL SALICYLATE

SMILES

OC1=C(C=CC=C1)C(=O)OC2=CC=CC=C2

InChI

InChIKey=ZQBAKBUEJOMQEX-UHFFFAOYSA-N
InChI=1S/C13H10O3/c14-12-9-5-4-8-11(12)13(15)16-10-6-2-1-3-7-10/h1-9,14H

HIDE SMILES / InChI

Molecular Formula C13H10O3
Molecular Weight 214.2167
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Phenyl salicylate belongs to the family of hydroxybenzoic acid derivatives. Phenyl salicylate is used as a food additive. Antimycobacterial activity of phenyl salicylates (salols) was studied in connection with antituberculotic activity of salicylic derivatives. Phenyl salicylates are esters. Phenyl salicylates (salols) represent a new group of antimycobacterial compounds. Phenyl salicylate is included in the number of medications, indicated for the treatment of symptoms of irritative voiding, used to relieve the discomfort, pain, frequent urge to urinate, and cramps/spasms of the urinary tract caused by an infection or a medical procedure. Phenyl salicylate works as a pain reliever in these combinations.

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency
49.78 µM [EC50]

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
PROSED EC

PubMed

Sample Use Guides

In Vivo Use Guide
One tablet of PROSED EC orally 4 times per day followed by liberal fluid intake. Each tablet of PROSED EC contains: Phenyl Salicylate 36.2 mg
Route of Administration: Oral
In Vitro Use Guide
Phenyl Salicylate at 10 uM increased the number of MCF-7 cells by approximately 1.8 fold
Substance Class Chemical
Record UNII
28A37T47QO
Record Status Validated (UNII)
Record Version